Objective:

To evaluate the association between the triglyceride-glucose (TyG) index and coronary heart disease (CHD) risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), specifically addressing the knowledge gap regarding the impact of type 2 diabetes mellitus (T2DM) on this relationship.

Approach:

Key Findings:

• TyG index positively correlated with CHD risk (OR = 2.035).
• T2DM also significantly associated with increased CHD risk (OR = 2.107).
• Stronger association between TyG and CHD in patients with T2DM (OR = 3.34) compared to those without (OR = 1.89).
• ROC-derived cut-off values for TyG were 7.992 for patients without T2DM and 9.005 for those with T2DM.

Interpretation:

The TyG index is a significant marker for assessing CHD risk in patients with MASLD, with its association being notably stronger in individuals with T2DM.

Limitations:

• Retrospective design may limit causal inferences, potentially affecting the reliability of the associations.
• Single-center study may affect generalizability to broader populations.
• Potential confounding factors not fully controlled could influence the results.

Conclusion:

The TyG index is significantly correlated with CHD risk in MASLD patients, with T2DM status modifying this relationship, suggesting the need for tailored risk assessment strategies in clinical practice.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.